International commission on obesity led by Auckland researcher

Prof Boyd Swinburn is a researcher in the School of Population Health at the University of Auckland. His work to improve our understanding and responses to obesity, under-nutrition and climate change is an AMRF Success Story. The AMRF is pleased to support Prof Swinburn’s research with a Kellaway Medical Research Fellowship. He will travel the ... Read more

Gastro-intestinal research from an early career scientist

Dr Tim Angeli is a Research Fellow in the Auckland Bioengingeering Institute at the University of Auckland. His research to improve our understanding of and develop treatments for gastro-intestinal disorders is an AMRF Success Story. The AMRF is pleased to support Dr Angeli’s research with an Edith C Coan Research Fellowship and an Emerging Researcher ... Read more

Fertility research shows low-cost, effective method to increase pregnancy rates

Prof Cindy Farquhar’s research, The IntraUterine Insemination (TUI) Study, shows that this low-cost treatment effectively increases pregnancy rates three-fold, and concludes that intrauterine insemination with ovarian stimulation should be offered to women with unexplained infertility as a first line treatment. The AMRF is pleased to see the publicity around this research we supported and we ... Read more

Prestigious cardiovascular publication for AMRF researchers

Dr David Crossman’s research team, including members from the Universities of Auckland, Exeter and Sydney as well as Yale University, is featured on the cover of the Oxford Academic journal Cardiovascular Research. With an impact factor of 5.9 and a featured editorial from one of the world’s leading experts in t-tubule remodelling in heart failure, ... Read more

Endometriosis Research in the News

Recent news highlights the struggle for understanding and diagnosis that women with endometriosis face. New research being undertaken by Dr Anna Ponnampalam at the Liggins Institute and the University of Auckland Department of Obstetrics and Gynaecology may lead to easier identification of the disease, as well as more effective treatments. Donate now to support endometriosis ... Read more

New cancer drug ‘could be a blockbuster’

AMRF Medical Committee member and grant holder A/Prof Lai-Ming Ching was on the front page of the Herald in part of a special series on cancer research in Auckland. Congratulations to A/Prof Ching and her team! Click here to support cancer drug research  Donate now Blockbuster Cancer Drug Research from Professor Lai-Ming Chen featured in ... Read more

Pain relief: New Zealand’s breakthrough in migraine treatment

The NZ Herald recently featured science successes, including the research of A/Prof Debbie Hay and Dr Chris Walker who are both recipients of AMRF funding used to research the treatment of ... Read more

Award-winning science communicator uses bioluminescence to explain how our body clock works

Online videos are the fasting growing source of content on the internet, and are becoming an increasingly popular format for communicating science. In this project, award-winning scientist Dr Siouxsie Wiles is working with professional graphic artist Luke Harris, and his team, to create a short animation using the New Zealand glow worm to introduce the ... Read more

Improving team collaboration in the operating theatre

AMRF funded research was recently profiled on One News. Recent, important studies have shown that failures in teamwork and team communication in the operating theatre (OT) lead directly to clinical errors and patient harm. Research also suggests that training as a team for those who are expected to work in teams can significantly reduce these ... Read more

Dr Ben Thompson: Developing New Treatments for Amblyopia or ‘Lazy Eye’

Amblyopia, also known as ’lazy eye‘, is the leading cause of childhood visual impairment in the developed world and affects about one in 30 people. The most common types of amblyopia cause poor vision in one eye and stop the two eyes working together effectively. Amblyopia also doubles the lifetime risk of serious visual impairment ... Read more